Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heath D Schmidt

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
CNS Neuroscience & Therapeutics|September 19, 2024
Revisiting dezocine for opioid use disorder: A narrative review of its potential abuse liabilityGordon A Barr, Heath D Schmidt, Ashish P Thakrar, et al.
British Journal of Pharmacology|December 2, 2024
Synergistic-like decreases in alcohol intake following combined pharmacotherapy with GLP-1 and amylin in male ratsCajsa Aranäs, Antonia Caffrey, Christian E Edvardsson, et al.
Substance Abuse|July 20, 2021
Interventions for hospitalized medical and surgical patients with opioid use disorder: A systematic reviewRachel French, Shoshana V Aronowitz, J Margo Brooks Carthon, et al.
Current Addiction Reports|November 23, 2020
Tobacco Smoking, Eating Behaviors, and Body Weight: A ReviewAriana M Chao, Thomas A Wadden, Rebecca L Ashare, et al.
Neuroscience Letters|September 15, 2023
A new formulation of dezocine, Cyc-dezocine, reduces oxycodone self-administration in female and male ratsHeath D Schmidt, Yafang Zhang, Jin Xi, et al.
Neuroscience Letters|December 26, 2016
Effects of LY466195, a selective kainate receptor antagonist, on ethanol preference and drinking in ratsDuncan Van Nest, Nicole S Hernandez, Henry R Kranzler, et al.
Journal of Neurotrauma|November 9, 2021
Endogenous Opioid Dynorphin Is a Potential Link between Traumatic Brain Injury, Chronic Pain, and Substance Use DisorderKaitlin M Best, Marissa M Mojena, Gordon A Barr, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 7, 2012
Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in ratsThomas J Hopkins, Laura E Rupprecht, Matthew R Hayes, et al.
Neuropharmacology|December 6, 2019
Administration of a novel high affinity PICK1 PDZ domain inhibitor attenuates cocaine seeking in ratsChristopher Turner, Marta De Luca, Jordan Wolfheimer, et al.
Nature Neuroscience|December 18, 2012
Epigenetic inheritance of a cocaine-resistance phenotypeFair M Vassoler, Samantha L White, Heath D Schmidt, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
CNS Neuroscience & Therapeutics|September 19, 2024
Revisiting dezocine for opioid use disorder: A narrative review of its potential abuse liabilityGordon A Barr, Heath D Schmidt, Ashish P Thakrar, et al.
British Journal of Pharmacology|December 2, 2024
Synergistic-like decreases in alcohol intake following combined pharmacotherapy with GLP-1 and amylin in male ratsCajsa Aranäs, Antonia Caffrey, Christian E Edvardsson, et al.
Substance Abuse|July 20, 2021
Interventions for hospitalized medical and surgical patients with opioid use disorder: A systematic reviewRachel French, Shoshana V Aronowitz, J Margo Brooks Carthon, et al.
Current Addiction Reports|November 23, 2020
Tobacco Smoking, Eating Behaviors, and Body Weight: A ReviewAriana M Chao, Thomas A Wadden, Rebecca L Ashare, et al.
Neuroscience Letters|September 15, 2023
A new formulation of dezocine, Cyc-dezocine, reduces oxycodone self-administration in female and male ratsHeath D Schmidt, Yafang Zhang, Jin Xi, et al.
Neuroscience Letters|December 26, 2016
Effects of LY466195, a selective kainate receptor antagonist, on ethanol preference and drinking in ratsDuncan Van Nest, Nicole S Hernandez, Henry R Kranzler, et al.
Journal of Neurotrauma|November 9, 2021
Endogenous Opioid Dynorphin Is a Potential Link between Traumatic Brain Injury, Chronic Pain, and Substance Use DisorderKaitlin M Best, Marissa M Mojena, Gordon A Barr, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 7, 2012
Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in ratsThomas J Hopkins, Laura E Rupprecht, Matthew R Hayes, et al.
Neuropharmacology|December 6, 2019
Administration of a novel high affinity PICK1 PDZ domain inhibitor attenuates cocaine seeking in ratsChristopher Turner, Marta De Luca, Jordan Wolfheimer, et al.
Nature Neuroscience|December 18, 2012
Epigenetic inheritance of a cocaine-resistance phenotypeFair M Vassoler, Samantha L White, Heath D Schmidt, et al.
Pageof 9